WATERS CORPORATION
NYSE: WAT (Waters Corporation)
Last update: 14 hours ago394.81
-1.56 (-0.39%)
| Previous Close | 396.37 |
| Open | 396.72 |
| Volume | 367,881 |
| Avg. Volume (3M) | 666,845 |
| Market Cap | 23,504,910,336 |
| Price / Earnings (TTM) | 36.22 |
| Price / Earnings (Forward) | 28.01 |
| Price / Sales | 7.65 |
| Price / Book | 10.16 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 22.02% |
| Operating Margin (TTM) | 22.93% |
| Diluted EPS (TTM) | 11.01 |
| Quarterly Revenue Growth (YOY) | 3.90% |
| Quarterly Earnings Growth (YOY) | 18.80% |
| Total Debt/Equity (MRQ) | 78.58% |
| Current Ratio (MRQ) | 1.81 |
| Operating Cash Flow (TTM) | 758.81 M |
| Levered Free Cash Flow (TTM) | 588.83 M |
| Return on Assets (TTM) | 11.61% |
| Return on Equity (TTM) | 40.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Mixed |
| Diagnostics & Research (Global) | Bullish | Mixed | |
| Stock | Waters Corporation | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.13 |
|
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.16% |
| % Held by Institutions | 98.23% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Fundsmith Llp | 30 Sep 2025 | 3,955,498 |
| Mawer Investment Management Ltd. | 30 Sep 2025 | 1,551,010 |
| Fundsmith Investment Services Ltd. | 30 Sep 2025 | 1,356,289 |
| Ako Capital Llp | 30 Sep 2025 | 806,948 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 423.00 (Morgan Stanley, 7.14%) | Hold |
| Median | 390.00 (-1.22%) | |
| Low | 325.00 (JP Morgan, -17.68%) | Hold |
| Average | 382.60 (-3.09%) | |
| Total | 1 Buy, 4 Hold | |
| Avg. Price @ Call | 360.13 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 423.00 (7.14%) | Hold | 398.62 |
| TD Cowen | 05 Nov 2025 | 390.00 (-1.22%) | Hold | 371.97 |
| Wells Fargo | 05 Nov 2025 | 385.00 (-2.48%) | Hold | 371.97 |
| JP Morgan | 09 Oct 2025 | 325.00 (-17.68%) | Hold | 330.45 |
| Rothschild & Co | 08 Oct 2025 | 390.00 (-1.22%) | Buy | 327.65 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 11 Nov 2025 | Announcement | Waters Corporation to Present at the Jefferies Global Healthcare Conference in London |
| 11 Nov 2025 | Announcement | Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software |
| 04 Nov 2025 | Announcement | Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results |
| 13 Oct 2025 | Announcement | Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics |
| 01 Oct 2025 | Announcement | Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |